A daily comprehensive muscle training programme increases lean mass and spontaneous activity in children with Prader-Willi syndrome after 6 months

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 1, 2006, Pages 65-74

  Schlumpf, Michael ^c   Eiholzer, Urs ^c   Gygax, Muriel ^c   Schmid, Silvia ^a   Van der Sluis, Inge ^b   l'Allemand, Dagmar ^c  

^a Prevmedic Bethanien Private Clinic   (Switzerland)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c Institute Growth Puberty Adolescence   (Switzerland)

Author keywords

Body composition; Fat mass; Lean mass; Physical activity; Prader Willi syndrome; Training programme

Indexed keywords

HUMAN GROWTH HORMONE;

ARTICLE; BODY COMPOSITION; BODY HEIGHT; CALORIC INTAKE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FUNCTIONAL ASSESSMENT; HOME CARE; HUMAN; KINESIOTHERAPY; LEAN BODY WEIGHT; PHYSICAL ACTIVITY; PRADER WILLI SYNDROME; PRETEST POSTTEST CONTROL GROUP DESIGN; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 32944471570     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.1.65     Document Type: Article

References (37)

1. Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myotonieartigern Zustand im Neugeborenenalter. Schweiz Med Wochenschr 1956; 86: 1260-1261.
2. Bray G, Dahms W, Swerdloss R, Fiser R, Atkinson R, Carrel X. The Prader-Willi syndrome. A study of 40 patients and a review of the literature. Medicine 1983; 62: 59-80.
3. Eiholzer U, Whitman BY. A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2004; 17: 1153-1175.
4. Carrel A, Myers S, Whitman B, Allen D. Growth hormone improves body composition, fat utilization, physical strength and agility in Prader-Willi syndrome: a controlled study. J Pediatr 1999; 134: 215-221.
5. Bekx MT, Carrel AL, Shriver TC, Li Z, Allen DB. becreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome, J Pediatr 2003; 143: 372-376.
6. Lindgren AC, Hagenas L, Muller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzen EM. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr 1998; 87: 28-3 1.
7. Eiholzer U, Blum WF, Molinari L. Body fat determined by skinfold measurements is elevated despite under- weight in infants with Prader-Labhart-Willi syndrome. J Pediatr 1999; 134: 222-225.
8. Eiholzer U, I'Allemand D, van der Sluis 1, Steinert H, Ellis K. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy. Horm Res 2000; 53: 200-206.
9. Eiholzer U, I'Allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. J Pediatr 2004; 144: 753-758.
10. I'Allemand D, Eiholzer U, Schlumpf M, Steinert H, Riesen W. Cardiovascular risk factors improve under 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr 2000; 159: 835-842.
11. Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 2001; 22: 787-799.
12. I'Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J. The carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Horm Res 2003; 59: 239-248.
13. Eiholzer U, Nordmann Y, I'Allemand D, Schlumpf M, Schmid S, Kromeyer-Hauschild K. Improving body composition and physical activity in Prader-Willi syndrome. J Pediatr 2003; 142: 73-78.
14. Eiholzer U, I'Allemand D. Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after four years of therapy. Horm Res 2000; 53: 185-192.
15. Stadler DD. Nutritional management. In: Greenswag LR, Alexander R, eds. Management of Prader-Willi Syndrome. New York: Springer-Verlag, 1995; 88-114.
16. Prader A, Largo R, Molinari L, Issler C. Physical growth of Swiss children form birth to 20 years of age. Heiv Paediatr Acta 1989; 43 (Suppl 52): 1-125.
17. Boot AM, Bouquet J, de Ridder MA, Krenning EP, de Muinck Keizer-Schrama SMPF. Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr 1997; 66: 232-238.
18. Zimmermann MB, Gubeli C, Puntener C, Molinari L. Detection of overweight and obesity in a national sample of 6-12-y-old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Prevention and the International Obesity Task Force. Am J Clin Nutr 2004; 79: 838-843.
19. Frost H, Lamb SE, Doll HA, Carver PT, Stewart-Brown S. Randomised controlled trial of physiotherapy compared with advice for low back pain. Br Med J 2004; 329: 708.
20. Pierson RN Jr, Wang J, Thornton JC. Measurement of body composition: applications in hormone research. Horm Res 1997; 48 (Suppl 1): 56-62.
21. Civardi C, Vicentini R, Grugni G, Cantello R. Corticospinal physiology in patients with Prader-Willi syndrome: a transcranial magnetic stimulation study. Arch Neurol 2004; 61: 1585-1589.
22. Lindgren AC, Hagenas L, Ritzen EM. Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Horm Res 1999; 51: 157-161.
23. Schwingshandl J, Sudi K, Eibl B, Wallner S, Borkenstein M. Effect of an individualised training programme during weight reduction on body composition: a randomised trial. Arch Dis Child 1999; 81: 426-428.
24. Goris AH, Westerterp MS, Westerterp KR. Under- eating and underrecording of habitual food intake in obese men: selective underreporting of fat intake. Am J Clin Nutr 2000; 71: 130-134.
25. Bandini LG, Schoeller DA, Cyr HN, Dietz WH. Validity of reported energy intake in obese and non-obese adolescents. Am J Clin Nutr 1990; 52: 421-425.
26. Braam. LAJLM, Ocke MC, Bueno-de-Mesquita HB, Seidell JC. Determinants of obesity-related underreporting of energy intake. Am J Epiderniol 1998; 147: 1081-1086.
27. van Mil EA, Westerterp KR, Gerver WJ, Curfs LM, Schrander-Stumpel CT, Kester AD, Saris WH. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. Am J Clin Nutr 2000; 71: 752-756.
28. van Mil EG, Westerterp KR, Kester AD, Curfs LM, Gerver WJ, Schrander-Stumpel CT, Saris WH. Activity related energy expenditure in children and adolescents with Prader-Willi syndrome. Int J Obes Relat Metab Disord 2000; 24: 429-434.
29. van Mil EG, Westerterp KR, Gerver WJ, Marken Lichtenbelt WD, Kester AD, Saris WH. Body composition in Prader-Willi syndrome compared with non-syndromal obesity: relationship to physical activity and growth hormone function. J Pediatr 2001; 139: 708-714.
30. Tudor-Locke C, Ainsworth BE, Thompson RW, Matthews CE. Comparison of pedometer and accelerometer measures of free-living physical activity. Med Sci Sports Exerc 2002; 34: 2045-205 1.
31. Bachmann, S. Wachstumshormon-Behandlung von jungen noch nicht adip6sen Kindern mit Prader-Willi Syndrom: Gewichtsverlauf und Einflussfaktoren. Dissertation, Zorich University, 2000; 10-20.
32. I'Allemand, D, Bachmann, S, Eiholzer U. Role of diet and upbringing in young children with Prader-Willi syndrome (PWS). In: Eiholzer U, I'Allemand D, Zipf WB, eds. Prader-Willi Syndrome as a Model for Obesity. Basel: Karger, 2003; 190-197.
33. Wollmann HA, Schultz U, Grauer M, Ranke M. Reference values for height and weight in Prader-Willi syndrome based on 315 patients. Eur J Pediatr 1998; 157: 634-642.
34. Hauffa BP. One-year results of growth hormone treatment of short stature in Prader-Willi syndrome. Acta Paediatr 1997; Suppl 243: 63-65.
35. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH. Effects of growth hormone on pulmonary filnction, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 2003; 88: 2206-2212.
36. Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 2002; 87: 1581-1585.
37. Eiholzer U. A comprehensive approach to limiting weight gain and to normalizing body composition in Prader-Willi syndrome. In: Eiholzer U, I'Allemand D, Zipf W, eds. Prader-Willi Syndrome as a Model for Obesity. Basel: Karger, 2003; 211-221.